GENE ONLINE|News &
Opinion
Blog

Antiviral
Ascletis Cleared By FDA To Begin Trial On Monkeypox Antiviral
2022-11-16
Second Monkeypox Death as Antiviral Enters Phase 3 Clinical Trial
2022-09-12
FDA Approves Roche’s Established Antiviral For Children Aged Five Or Older
2022-08-12
Pfizer to Address COVID-19 Reinfection After Paxlovid Treatment
2022-05-19
China Gives Conditional Approval to Pfizer’s Covid-19 Oral Antiviral
2022-02-14
Remdesivir Cleared for Treating Non-Hospitalized COVID-19 Patients
2022-01-24
Shanghai’s Everest Medicines Licenses COVID-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
Pfizer’s COVID-19 Oral Antiviral Cuts Hospitalization and Death By 89%
2021-11-05
Singapore Becomes Latest Asian Country to Sign Merck Deal for Oral COVID-19 Pill
2021-10-06
Merck Announces Its Oral COVID-19 Drug Cuts Risk of Hospitalization and Death by 50%
2021-10-01
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
Regeneron Secures $4.5 Billion Worth of Contracts from the US for Combating COVID-19
2020-07-10
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
Pharma Firm AnGes and Osaka University to Initiate Coronavirus Vaccine Testing on Animals
2020-03-25
Purine Repressing Probiotic Might Halt COVID-19, says Korean Researchers
2020-03-21
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top